Science Explorer Back to mapMap
Discussion
Company · Durham · United States

Scynexis (United States)

scynexis.comROR OpenAlex
Research works
71
▼ 61% vs 2018-21
Citations
2.5k
34.8 per fractional work
Top-10% rate
8.1%
all institutions 10.0%
Open access
51%
world 40%
International
20%
world 18%
Scynexis (United States)

Not ranked overall: Scynexis (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Scynexis (United States) work in?

In all years, 51% of research at Scynexis (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (23%), Chemistry (8%). It does 2.1× the world's share of Life Sciences.

Health Sciences: 36 fractional works · 50.5% of its workMedicine: 35 fractional works · 48.8% of its workEpidemiology: 13 fractional works · 18.7% of its workInfectious Diseases: 10 fractional works · 13.6% of its workPharmacology: 3 fractional works · 4.3% of its workOncology: 2 fractional works · 3.2% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 2.7% of its workHepatology: 1 fractional works · 1.2% of its workReproductive Medicine: 1 fractional works · 0.8% of its workSurgery: 0 fractional works · 0.6% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.4% of its workOphthalmology: 0 fractional works · 0.3% of its workEmergency Medicine: 0 fractional works · 0.2% of its workRehabilitation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.7% of its workVeterinary: 1 fractional works · 1.2% of its workSmall Animals: 1 fractional works · 1.2% of its workHealth Professions: 0 fractional works · 0.4% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 26 fractional works · 36.0% of its workBiochemistry, Genetics and Molecular Biology: 17 fractional works · 23.5% of its workMolecular Biology: 12 fractional works · 17.4% of its workBiophysics: 1 fractional works · 2.0% of its workCell Biology: 1 fractional works · 2.0% of its workBiotechnology: 1 fractional works · 1.2% of its workBiochemistry: 0 fractional works · 0.3% of its workMolecular Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workImmunology and Microbiology: 4 fractional works · 6.0% of its workMicrobiology: 2 fractional works · 3.5% of its workParasitology: 1 fractional works · 1.5% of its workImmunology: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 3 fractional works · 4.7% of its workPlant Science: 1 fractional works · 1.2% of its workInsect Science: 1 fractional works · 1.1% of its workAnimal Science and Zoology: 1 fractional works · 1.1% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.6% of its workFood Science: 0 fractional works · 0.5% of its workAgronomy and Crop Science: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 1.1% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmacology: 1 fractional works · 0.7% of its workPhysical Sciences: 10 fractional works · 13.5% of its workChemistry: 5 fractional works · 7.7% of its workOrganic Chemistry: 5 fractional works · 6.4% of its workSpectroscopy: 1 fractional works · 1.1% of its workInorganic Chemistry: 0 fractional works · 0.2% of its workEngineering: 2 fractional works · 3.0% of its workMechanical Engineering: 1 fractional works · 1.2% of its workBiomedical Engineering: 1 fractional works · 0.9% of its workElectrical and Electronic Engineering: 0 fractional works · 0.5% of its workMechanics of Materials: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 1 fractional works · 1.3% of its workComputational Theory and Mathematics: 1 fractional works · 1.3% of its workEnvironmental Science: 1 fractional works · 0.7% of its workEcology: 0 fractional works · 0.4% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.7% of its workBiomaterials: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.0% of its workALL ITS WORKScynexis (UnitedStates)71fractional works, all years
Life Sciences36%Physical Sciences13%Health Sciences51%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 16 fields, with their numbers
    1. Medicine3548.8%
    2. Veterinary11.2%
    3. Health Professions00.4%
    4. Nursing00.1%
    5. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology1723.5%
    2. Immunology and Microbiology46.0%
    3. Agricultural and Biological Sciences34.7%
    4. Neuroscience11.1%
    5. Pharmacology, Toxicology and Pharmaceutics10.7%
    1. Chemistry57.7%
    2. Engineering23.0%
    3. Computer Science11.3%
    4. Environmental Science10.7%
    5. Materials Science00.7%
    6. Physics and Astronomy00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Scynexis (United States)?

Ranked on the quality score, David A Angulo, Robert T. Jacobs and Stephen A. Wring lead among researchers whose main affiliation is Scynexis (United States).

  1. 1 David A Angulo United States · #330,464 worldwide 1.8k citations · 55 works
  2. 2 Robert T. Jacobs United States · #459,242 worldwide 3.2k citations · 67 works
  3. 3 Stephen A. Wring United States · #462,033 worldwide 5.3k citations · 81 works
  4. 4 Bakela Nare United States · #491,511 worldwide 3.7k citations · 56 works
  5. 5 Bernard Scorneaux United States · #961,264 worldwide 1.7k citations · 24 works
  6. 6 Michael R. Peel United States · #1,622,468 worldwide 1.5k citations · 51 works
  7. 7 Ryan Randolph United States · #2,163,439 worldwide 732 citations · 18 works
  8. 8 Brian H. Heasley United States · #2,192,132 worldwide 835 citations · 22 works
  9. 9 Paul Kowalczyk United States · #2,201,998 worldwide 841 citations · 16 works
  10. 10 Eric Gaukel United States · #2,206,559 worldwide 620 citations · 15 works
All ranked researchers at Scynexis (United States)

What are the most cited papers from Scynexis (United States)?

The most cited paper from Scynexis (United States) is "Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond" (Wesley C. Van Voorhis et al., 2016), with 452 citations. Next come "The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation" (405) and "CNS 7056" (405).

Most cited papers
#PaperReleasedCitations
1 Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond Wesley C. Van Voorhis et al. · PLoS Pathogens Open access187 authors 28 Jul 2016 452
2 The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation Emily L. Larkin, Christopher L. Hager, Jyotsna Chandra et al. · Antimicrobial Agents and Chemotherapy Open access 21 Feb 2017 405
3 CNS 7056 Gavin J. Kilpatrick, Margaret McIntyre, Richard F. B. Cox et al. · Anesthesiology 20 Jun 2007 405
4 The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases Thomas Spangenberg, Jeremy Nicholas Burrows, Paul Kowalczyk et al. · PLoS ONE Open access 17 Jun 2013 347
5 SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis Robert T. Jacobs et al. · PLoS neglected tropical diseases Open access 28 Jun 2011 309
All 60 most cited papers, with filters and sorting

Which keywords describe research at Scynexis (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antifungal Therapy, Immunocompromised Patients, Candidiasis, Invasive Fungal Infections, Diagnosis, Drug Resistance and Cancer Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology19▲ 6.7×21 topics
  2. Antifungal Therapy15▲ 209×3 topics
  3. Immunocompromised Patients8▲ 165×2 topics
  4. Candidiasis8▲ 218×1 topic
  5. Invasive Fungal Infections8▲ 272×1 topic
  6. Diagnosis6▲ 7.7×5 topics
  7. Drug Resistance5▲ 22×4 topics
  8. Cancer Therapy4▲ 9.5×5 topics
  9. Fungal Pathogens4▲ 31×2 topics
  10. Cryptococcal Disease4▲ 165×1 topic
  11. Dermatophytes4▲ 173×1 topic
  12. Histoplasmosis4▲ 165×1 topic
  13. Onychomycosis4▲ 173×1 topic
  14. Transcriptional Regulation3▲ 18×3 topics
  15. Genome Sequence3▲ 38×3 topics
  16. Medicinal Chemistry3▲ 11×3 topics
  17. Calcineurin3▲ 188×1 topic
  18. NFAT3▲ 188×1 topic
  19. Antioxidant Activity3▲ 7.0×3 topics
  20. Biological Activities3▲ 19×2 topics
  21. Vaccine Development3▲ 12×5 topics
  22. Sexually Transmitted Infections2▲ 62×1 topic
  23. Vaginal Microbiome2▲ 115×1 topic
  24. Angiogenesis2▲ 8.2×4 topics
  25. Anticancer Agents2▲ 13×4 topics
  26. Apoptosis2▲ 8.6×5 topics
  27. Chagas Disease2▲ 124×1 topic
  28. Chemotherapy2▲ 4.8×2 topics
  29. Polysaccharides2▲ 41×2 topics
  30. Trypanosoma cruzi2▲ 124×1 topic
  31. Vector Control2▲ 29×2 topics
  32. Antimicrobial Activity2▲ 17×3 topics
  33. Immune Response2▲ 5.1×7 topics
  34. Pharmacology2▲ 9.8×4 topics
  35. Medicinal Plants2▲ 8.4×5 topics
  36. Anti-inflammatory2▲ 11×6 topics
  37. Heterocyclic Compounds2▲ 18×2 topics
  38. Immunomodulating Compounds2▲ 70×1 topic
  39. Medicinal Mushrooms2▲ 70×1 topic
  40. Tumor Microenvironment2▲ 7.9×3 topics

Which research topics does Scynexis (United States) publish most on?

By volume in 2022-now: Antifungal resistance and susceptibility, Reproductive tract infections research, Nail Diseases and Treatments and Cervical Cancer and HPV Research.

Antifungal resistance an…1Antifungal resistance and susceptibility: 1 fractional worksReproductive tract infections research: 1 fractional worksNail Diseases and Treatments: 1 fractional worksCervical Cancer and HPV …0Cervical Cancer and HPV Research: 0 fractional worksFungal Infections and St…0Fungal Infections and Studies: 0 fractional worksNatural product bioactiv…0Natural product bioactivities and synthesis: 0 fractional worksPhytochemical compounds biological activities: 0 fractional worksFungal Biology and Applications: 0 fractional worksOvarian function and disorders: 0 fractional worksParasitic Diseases Research and Treatment: 0 fractional works
Infectious DiseasesMicrobiologyEpidemiologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antifungal resistance and susceptibility Infectious Diseases 1 works
  2. 2 Reproductive tract infections research Microbiology 1 works
  3. 3 Nail Diseases and Treatments Epidemiology 1 works
  4. 4 Cervical Cancer and HPV Research Epidemiology 0 works
  5. 5 Fungal Infections and Studies Epidemiology 0 works
  6. 6 Natural product bioactivities and synthesis Molecular Biology 0 works
  7. 7 Phytochemical compounds biological activities Molecular Biology 0 works
  8. 8 Fungal Biology and Applications Pharmacology 0 works
  9. 9 Ovarian function and disorders Reproductive Medicine 0 works
  10. 10 Parasitic Diseases Research and Treatment Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.9%not open49.1%

World: 40% of research is openly available.

with international co-authors19.8%domestic only80.2%

World: 18% is written across borders.

How has Scynexis (United States)'s research output changed?

Output in 2022-2025 was 61% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Scynexis (United States) as a percentage of every work published that year, 0.0000045% in 2024.

still counting0.00010%0.00020%0.00030%Scynexis (United States)0.000016% in 202519801990200020102020

Fractional works of Scynexis (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Durham

All research institutions in Durham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Scynexis (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.